Link Between Metabolic Syndrome and Insulin Levels in Older Adults

Understanding Metabolic Syndrome

Metabolic syndrome is characterized by a cluster of metabolic abnormalities that elevate an individual’s risk of developing diabetes and heart disease. The components of metabolic syndrome include:

– High blood sugar
– Excessive body fat around the waist
– Elevated lipid levels in the bloodstream
– Low levels of “good” cholesterol
– High blood pressure

Individuals are diagnosed with metabolic syndrome if they present at least three of these abnormalities.

Insulin’s Role in Metabolic Syndrome

Previous research has indicated that insulin-related issues may be central to metabolic syndrome. Insulin is a hormone produced by the pancreas that facilitates the removal of glucose from the bloodstream, allowing for its storage in the liver, muscles, or fat tissue. It is typically released when blood sugar levels rise, such as after meals.

Insulin resistance, a condition where the body fails to respond to insulin effectively, often leads to consistently high blood sugar levels. In response, the body increases insulin production, resulting in elevated insulin levels, which could serve as a marker for insulin resistance and metabolic syndrome. However, the impact of age and ethnicity on this relationship remains unclear.

Recent Research in Taiwan

Researchers in Taiwan conducted a study to determine whether elevated insulin levels in elderly Asian adults could predict the likelihood of having metabolic syndrome. Their findings were published in the journal BMJ Open.

The study involved 321 participants, including 210 women and 111 men aged between 50 and 90 years, with an average age of 64. None of the participants had diabetes. They completed lifestyle and social status questionnaires and underwent medical examinations, which included measuring their blood insulin levels and other components of metabolic syndrome. Insulin levels were assessed in the serum after an overnight fast to ensure accurate baseline measurements.

Findings on Insulin Levels and Metabolic Syndrome

Approximately one-third of the participants were diagnosed with metabolic syndrome. The study revealed that individuals with higher fasting insulin levels were significantly more likely to have this condition. Specifically, those in the highest insulin level group were ten times more likely to be affected compared to those in the lowest group. Participants with elevated insulin levels also exhibited increased rates of high blood pressure, abdominal obesity, high blood sugar, high blood lipids, and low levels of “good” cholesterol. Factors such as smoking status, gender, exercise habits, and marital status did not appear to influence the prevalence of metabolic syndrome.

To further investigate the relationship, researchers adjusted for various factors, including gender, age, obesity, smoking, high blood pressure, and elevated blood lipid levels. Even after accounting for these variables, participants with high fasting insulin levels remained five times more likely to have metabolic syndrome.

Interpreting the Results

The researchers acknowledged several limitations of their study. Being strictly observational, they could not definitively determine whether high insulin levels cause metabolic syndrome or if they are merely a symptom. Additionally, the participant pool was relatively small and skewed towards women.

Despite these limitations, the researchers propose that insulin levels may serve as a valuable clinical marker for metabolic syndrome. Elderly individuals with elevated insulin levels could be at a heightened risk for this syndrome and its associated severe health complications. The researchers plan to continue monitoring these individuals to evaluate whether lifestyle changes, such as increased physical activity and improved dietary habits, can yield positive health outcomes.

Reference

Chen, Y.-H., Lee, Y.-C., Tsao, Y.-C., Lu, M.-C., Chuang, H.-H., Yeh, W.-C., Tzeng, I.-S. & Chen, J.-Y. Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan. BMJ Open 8 (2018).